Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

KAIST researchers unveil a new cancer therapy that reprograms immune cells inside tumours, eliminating lab-based CAR ...

The first leukaemia patient to receive a breakthrough treatment since it was made available on the NHS has said it was ...

EUDA Health Holdings Limited (NASDAQ: EUDA) ('EUDA” or the 'Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that its ...

Better treatment options have improved survival rates in the U.S., according to a report from the American Cancer Society.

The first leukaemia patient receives a breakthrough treatment since it was made available on the NHS and commented that it ...

ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer is undetectable. This is the first phase. Most patients receive a "triplet" ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Scientists have shown that a non-invasive sound stimulation of the brain at a specific frequency can clear toxic proteins ...

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...